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peptides were blasted against the IMGT IGHV germline database 3 using IgBLAST (http://www.ncbi.nlm.nih.gov/igblast/).
Confirmatory searches were then performed against a combination of all three datasets (VHref-CSF plus VHref-PB plus UniProtKB). OCB peptides from a certain patient's CSF mapping to only the same patient's IgG-VH were identified as "patient-specific" (Tables S2 and S3 ). Patient non-specific OCB peptides mapped to IgG-VH transcripts of >1 patient or could not be assigned to the same patient's IgG-VH (Table S4 ) and were not analyzed further. Mass spectra of all "patient-specific" peptides were manually inspected to assess the quality of the match and importantly, to establish the extent of peptide sequence coverage by the detected product ions. Only OCB peptide sequences for which full tandem mass-spectrometry evidence was seen were utilized in further analysis. Table S3 : OCB Peptides. Summary of patient-specific and fully sequence-confirmed OCB peptides. Peptides are ordered by patient (Pat ID); shown are the peptide AA sequences (OCB Peptide), IGHV/IGHJ usage, and H-CDR3 regions representative of the associated IgG-VH cluster. Peptides marked with a "*" are identical to the respective IGHV germline sequence; AA mutations in comparison to the closest IGHV are in bold letters and shaded in gray. The column "Mutated?" lists whether a peptide is identical to germline ("n", not mutated); different from germline ("y"; yes); or contains >2 aminoacids mapping to the H-CDR region (CDR3). Compartmental distribution of IgG-VH clusters is "Cluster Compartment"; "C" are CSF-restricted clusters identified in VHref-CSF; "B,C" are clusters identified in VHref-CSF with contributions from blood and CSF; "B" is a cluster in patient MS-1 identified in VHref-PB. IEF gel band from which a peptide was obtained by mass-spectrometry is shown in column "IEF". Peptides belonging to IgG-VH clusters detected in >1 band on IEF of the same patient's OCB are labeled "y" (yes) in column "Multi band", "n" (no) if only detected in a single band. Boxed are peptides belonging to the same IgG-VH cluster. Shaded in gray is an OCB peptide that could not be matched to the same patient's VHref-CSF but instead mapped exclusively to this patient's IgG-VH in VHref-PB; this peptide is highly private to patient MS-1 as it is entirely H-CDR derived. Table S4 : "Patient-specific" and fully sequence-confirmed OCB peptides. OCB peptides were termed "patient-specific" if they were found in the same patient's CSF IgG proteome and transcriptome (column "Pts in VHref-CSF"). In this table, the first column (CSF) denotes the CSF in which the indicated peptide (OCB Peptide) was identified using mass-spectrometry. In column "VHref-CSF" numbers of individual IgG-VH sequences containing exact sequence matches of the indicated OCB peptides as found in each patient are shown. The same OBC peptides as in Table S3 are represented here, except for peptide VMGFYEDSGYR from patient MS-1 which was private to this patient in VHref-PB. 12
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Supplemental Figure S1 Figure S1: OCB peptides displayed on representative IgG--VH sequences. OCB peptides are indicated in different colors; identical or very similar colors do not necessarily indicate identical OCB peptides. For additional information refer to Table S3 .
